Personalized Substance Control and Delivery Systems
Legal Citation
Summary of the Inventive Concept
A next-generation system for controlling and delivering substances, utilizing real-time data analytics, AI-powered control units, and modular, wearable, or handheld devices to optimize substance stability, potency, and personalized delivery.
Background and Problem Solved
The original patent disclosed devices, systems, and methods for controlling conditions and delivery of substances, addressing the limitations of environmental conditions affecting drug activity. However, these solutions were limited to controlling a few environmental conditions and lacked real-time data analytics, AI-powered control, and modular design. The new inventive concept addresses these limitations by providing a more comprehensive and adaptive approach to substance control and delivery.
Detailed Description of the Inventive Concept
The new inventive concept comprises a system of wearable or handheld substance containers with integrated sensors for monitoring user biometrics and environmental conditions, and a control unit for adjusting substance delivery based on real-time data analytics. The system can dynamically adjust storage conditions to optimize substance stability and potency, and features a modular design with interchangeable substance containers and a cloud-based control system for remote monitoring and control. Additionally, the system includes a smart substance delivery device with an AI-powered control unit and a mobile app for personalized dosage recommendations and real-time monitoring of substance efficacy. The decentralized substance management network ensures secure and transparent tracking of substance origin, quality, and movement.
Novelty and Inventive Step
The new inventive concept introduces the use of real-time data analytics, AI-powered control units, and modular design, which are not present in the original patent. The combination of these features provides a more comprehensive and adaptive approach to substance control and delivery, making the original inventive concept obsolete.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include implantable substance containers, ingestible sensors, or nanotechnology-based substance delivery systems. Variations could also include integrating the system with electronic health records, telemedicine platforms, or artificial intelligence-powered medical diagnosis tools.
Potential Commercial Applications and Market
The new inventive concept has significant commercial potential in the pharmaceutical, biotechnology, and healthcare industries, particularly in the areas of personalized medicine, precision therapy, and digital health. The system's ability to optimize substance stability, potency, and delivery could lead to improved treatment outcomes, reduced healthcare costs, and enhanced patient experiences.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61J1/16 |
| A | A61 | A61J1/165 |
| A | A61 | A61M5/445 |
| F | F25 | F25B21/04 |
| A | A61 | A61J2200/72 |
| A | A61 | A61M5/44 |
| A | A61 | A61M2205/3368 |
| A | A61 | A61M2205/3584 |
| A | A61 | A61M2205/3606 |
| A | A61 | A61M2205/3633 |
| A | A61 | A61M2205/3673 |
| A | A61 | A61M2205/8206 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device technology focused on substance storage, environmental control, and delivery systems, specifically pharmaceutical containment and monitoring technologies with expertise in sensor integration, environmental condition management, and medical device design
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device designer with advanced knowledge of sensor technologies, environmental control systems, and pharmaceutical storage requirements, typically holding a master's degree with 3-5 years of industry experience in medical device development
Obviousness Rationale
A PHOSITA would recognize that the PTD's AI-powered, data-driven substance control system represents a predictable technological evolution of the source patent's environmental control sleeve, leveraging known sensor integration and data analytics techniques to enhance substance monitoring and delivery capabilities. The fundamental concept of controlling substance environmental conditions remains consistent, with the PTD merely applying contemporary technological approaches to expand the original patent's core functionality.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,495 |
|---|---|
| Title | Devices, systems and methods for controlling conditions and delivery of substances |